#arteritis

@europeanjournalofneurology.ean.org

2 months ago

GCA should be considered in IS/TIA patients ≥ 50 years with vertebrobasilar or multiterritorial involvement, or recurrent IS/TIA despite secondary prevention.

📚 Read the recently published article now: onlinelibrary.wiley.com/doi/10.1111/...

#Arteritis #Stroke #TIA
@ean.org #WileyNeuro

1 0 0 0

Journal of Internal Medicine

@jinternmed.bsky.social

4 months ago

The November issue is now online!

👉 Read our latest articles!

🔗 onlinelibrary.wiley.com/toc/13652796/2025/298/5

#kidneys #CKD #neuroendocrinology #addiction #antibiotics #arteritis #PMR #retroperitoneal #fibrosis #anticoagulation #gastrointestinal #bleeding #atrialfibrillation #HDL #coronary

0 0 0 0

Springer Medicine

@springermedicine.com

9 months ago

Precision Over Prednisone: Innovative Treatment Strategies for Giant Cell Arteritis Tocilizumab has emerged as a promising treatment option for giant cell arteritis, demonstrating significant potential to reduce glucocorticoid dependence. But unanswered questions remain, such as the…

#Tocilizumab has emerged as a promising treatment option for giant cell #arteritis, demonstrating significant potential to reduce glucocorticoid dependence. But unanswered questions remain.

Find out more in this #EdsChoice review 👉 buff.ly/Vnm4kN9

#RheumSky #MedSky

0 0 0 0

Springer Medicine

@springermedicine.com

9 months ago

Takayasu arteritis complicated by SAPHO syndrome: A case-based review Two patients presenting with anterior chest pain were diagnosed with Takayasu arteritis co-existing with SAPHO syndrome, a rare inflammatory osteoarticular disorder. Their symptoms improved with…

#MedCase - Two patients presenting with anterior chest pain were diagnosed with Takayasu #arteritis co-existing with #SAPHO syndrome, a rare inflammatory osteoarticular disorder. Their symptoms improved with glucocorticoids and biologic agents.

👉 buff.ly/cmQEeQV

#RheumSky

0 0 0 0

Saori Abe

@oriabe114.bsky.social

11 months ago

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis | NEJM Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a selective Janus kinase (JAK) inhibitor that blocks the signaling of several...

A Phase 3 Trial of #Upadacitinib for Giant-Cell Arteritis | NEJM
www.nejm.org/doi/full/10....

“In patients with giant-cell #arteritis, upadacitinib at a dose of 15 mg — but not 7.5 mg — with a 26-week glucocorticoid taper showed efficacy superior to that of placebo.”
#Rheumsky #GCA

7 1 0 0

Bibliosalut

@bibliosalut.bsky.social

11 months ago

#PublicaSalutIB 👴🏥 Reumatologia de Son Llatzer ha participat en un estudi sobre la mortalitat en pacients amb arteritis de cèl·lules gegants a Espanya www.infosalut.com/investigacio/estudis-i-p... https://doi.org/10.1186/s13075-024-03468-6

#reumatologia #mortalitat #arteritis

0 0 0 0

Infosalut

@infosalut.bsky.social

1 year ago

#PublicaSalutIB 👴🏥 Reumatología de Son Llatzer ha participado en un estudio sobre la mortalidad en pacientes con arteritis de células gigantes en España www.infosalut.com/investigacio/estudis-i-p...

#reumatología #mortalidad #arteritis

1 0 0 0

Infosalut

@infosalut.bsky.social

1 year ago

#PublicaSalutIB 👴🏥 Reumatologia de Son Llatzer ha participat en un estudi sobre la mortalitat en pacients amb arteritis de cèl·lules gegants a Espanya www.infosalut.com/investigacio/estudis-i-p... https://doi.org/10.1186/s13075-024-03468-6

#reumatologia #mortalitat #arteritis